| Clinical development of new drug–radiotherapy combinations RA Sharma, R Plummer, JK Stock, TA Greenhalgh, O Ataman, S Kelly, ... Nature reviews Clinical oncology 13 (10), 627-642, 2016 | 313 | 2016 |
| UK consensus on normal tissue dose constraints for stereotactic radiotherapy GG Hanna, L Murray, R Patel, S Jain, KL Aitken, KN Franks, N Van As, ... Clinical Oncology 30 (1), 5-14, 2018 | 268 | 2018 |
| Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement M Guckenberger, C Belka, A Bezjak, J Bradley, ME Daly, D DeRuysscher, ... Radiotherapy and Oncology 146, 223-229, 2020 | 264 | 2020 |
| Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ... Journal of thoracic oncology 14 (12), 2109-2119, 2019 | 263 | 2019 |
| ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer U Nestle, D De Ruysscher, U Ricardi, X Geets, J Belderbos, C Pöttgen, ... Radiotherapy and oncology 127 (1), 1-5, 2018 | 195 | 2018 |
| Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a … AO Clive, H Taylor, L Dobson, P Wilson, E de Winton, N Panakis, ... The Lancet Oncology 17 (8), 1094-1104, 2016 | 180 | 2016 |
| Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from … N Girard, J Bar, P Garrido, MC Garassino, F McDonald, F Mornex, ... Journal of Thoracic Oncology 18 (2), 181-193, 2023 | 132 | 2023 |
| Lung stereotactic body radiotherapy with an MR-linac–Quantifying the impact of the magnetic field and real-time tumor tracking MJ Menten, MF Fast, S Nill, CP Kamerling, F McDonald, U Oelfke Radiotherapy and Oncology 119 (3), 461-466, 2016 | 111 | 2016 |
| The dandelion dilemma revisited for oligoprogression: treat the whole lawn or weed selectively? PH Patel, D Palma, F McDonald, AC Tree Clinical Oncology 31 (12), 824-833, 2019 | 97 | 2019 |
| Systemic treatment of brain metastases in non-small cell lung cancer S Page, C Milner-Watts, M Perna, U Janzic, N Vidal, N Kaudeer, M Ahmed, ... European Journal of Cancer 132, 187-198, 2020 | 90 | 2020 |
| Management of stage I and II nonsmall cell lung cancer F McDonald, M De Waele, LEL Hendriks, C Faivre-Finn, AMC Dingemans, ... European Respiratory Journal 49 (1), 2017 | 90 | 2017 |
| Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation F McDonald, S Lalondrelle, H Taylor, K Warren-Oseni, V Khoo, ... Clinical Oncology 25 (9), 549-556, 2013 | 83 | 2013 |
| UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy P Diez, GG Hanna, KL Aitken, N Van As, A Carver, RJ Colaco, J Conibear, ... Clinical Oncology 34 (5), 288-300, 2022 | 80 | 2022 |
| Practical management of oligometastatic non–small-cell lung cancer K Jasper, B Stiles, F McDonald, DA Palma Journal of Clinical Oncology 40 (6), 635-641, 2022 | 74 | 2022 |
| Magnetic resonance imaging in precision radiation therapy for lung cancer H Bainbridge, A Salem, RHN Tijssen, M Dubec, A Wetscherek, C Van Es, ... Translational lung cancer research 6 (6), 689, 2017 | 74 | 2017 |
| Treating locally advanced lung cancer with a 1.5 T MR-Linac–Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated … HE Bainbridge, MJ Menten, MF Fast, S Nill, U Oelfke, F McDonald Radiotherapy and oncology 125 (2), 280-285, 2017 | 73 | 2017 |
| Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment S Hafeez, F McDonald, S Lalondrelle, H McNair, K Warren-Oseni, ... International Journal of Radiation Oncology* Biology* Physics 98 (1), 115-122, 2017 | 73 | 2017 |
| Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic C Faivre-Finn, JD Fenwick, KN Franks, S Harrow, MQF Hatton, C Hiley, ... Clinical Oncology 32 (8), 481-489, 2020 | 66 | 2020 |
| Prospective study delivering simultaneous integrated high-dose tumor boost (≤ 70 Gy) with image guided adaptive radiation therapy for radical treatment of localized muscle … S Hafeez, K Warren-Oseni, HA McNair, VN Hansen, K Jones, M Tan, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1022-1030, 2016 | 64 | 2016 |
| Targeting the PD-1/PD-L1 axis in non–small cell lung cancer R Kumar, D Collins, S Dolly, F McDonald, MER O’Brien, TA Yap Current problems in cancer 41 (2), 111-124, 2017 | 52 | 2017 |
